Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Debnath

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Cancer Drug Targets|April 3, 2024
Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive ReviewAbhijit Debnath, Rupa Mazumder
Inflammopharmacology|February 12, 2026
Hydrogel-enabled drug delivery for ulcerative colitisMohit Sharma, Rupa Mazumder, Abhijit Debnath
Environmental Science and Pollution Research International|February 3, 2022
Vehicular traffic noise modelling of urban area-a contouring and artificial neural network based approachAbhijit Debnath, Prasoon Kumar Singh, Sushmita Banerjee
Current Computer-Aided Drug Design|January 8, 2025
Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro ApproachesNeha Sharma, Rupa Mazumder, Pallavi Rai, et al.
Current Topics in Medicinal Chemistry|January 16, 2026
Emerging Multi-Target Therapies for Type 2 Diabetes: Bridging Drug Innovation and Precision DeliveryPriya Singhal, Rupa Mazumder, Anjna Rani, et al.
Current Pharmaceutical Design|March 1, 2026
Transferosomes: A Vesicular Tool for Transdermal Drug DeliveryArpita Dua, Rupa Mazumder, Abhijit Debnath, et al.
Current Drug Metabolism|October 14, 2025
Development of Transdermal Drug Delivery Approaches to Combat Diabetes: An UpdatePriya Singhal, Rupa Mazumder, Anjna Rani, et al.
Journal of Environmental Management|August 26, 2021
Metallic contamination of global river sediments and latest developments for their remediationAbhijit Debnath, Prabhat Kumar Singh, Yogesh Chandra Sharma
Current Drug Targets|April 1, 2026
PTP1B Inhibitors for Type 2 Diabetes: From Natural Products, Synthetic Inhibitors, and Multi-Target Drug Design Strategies to Clinical TranslationPallavi Joshi, Avijit Mazumder, Bhavani Pentela, et al.
Chemical Biology & Drug Design|September 4, 2024
Role of PD-1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and ResistanceNeha Sharma, Rupa Mazumder, Pallavi Rai, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Cancer Drug Targets|April 3, 2024
Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive ReviewAbhijit Debnath, Rupa Mazumder
Inflammopharmacology|February 12, 2026
Hydrogel-enabled drug delivery for ulcerative colitisMohit Sharma, Rupa Mazumder, Abhijit Debnath
Environmental Science and Pollution Research International|February 3, 2022
Vehicular traffic noise modelling of urban area-a contouring and artificial neural network based approachAbhijit Debnath, Prasoon Kumar Singh, Sushmita Banerjee
Current Computer-Aided Drug Design|January 8, 2025
Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro ApproachesNeha Sharma, Rupa Mazumder, Pallavi Rai, et al.
Current Topics in Medicinal Chemistry|January 16, 2026
Emerging Multi-Target Therapies for Type 2 Diabetes: Bridging Drug Innovation and Precision DeliveryPriya Singhal, Rupa Mazumder, Anjna Rani, et al.
Current Pharmaceutical Design|March 1, 2026
Transferosomes: A Vesicular Tool for Transdermal Drug DeliveryArpita Dua, Rupa Mazumder, Abhijit Debnath, et al.
Current Drug Metabolism|October 14, 2025
Development of Transdermal Drug Delivery Approaches to Combat Diabetes: An UpdatePriya Singhal, Rupa Mazumder, Anjna Rani, et al.
Journal of Environmental Management|August 26, 2021
Metallic contamination of global river sediments and latest developments for their remediationAbhijit Debnath, Prabhat Kumar Singh, Yogesh Chandra Sharma
Current Drug Targets|April 1, 2026
PTP1B Inhibitors for Type 2 Diabetes: From Natural Products, Synthetic Inhibitors, and Multi-Target Drug Design Strategies to Clinical TranslationPallavi Joshi, Avijit Mazumder, Bhavani Pentela, et al.
Chemical Biology & Drug Design|September 4, 2024
Role of PD-1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and ResistanceNeha Sharma, Rupa Mazumder, Pallavi Rai, et al.
Pageof 5